Navis G - Search Results

1

Angiotensin I-converting enzyme: a pathogenetic role in diabetic renal damage?

Lely AT, Luik PT, Navis G. Lely AT, et al. Among authors: navis g. Curr Diabetes Rev. 2007 Feb;3(1):41-52. doi: 10.2174/157339907779802049. Curr Diabetes Rev. 2007. PMID: 18220655 Review.

2

Proteinuria and progression of renal disease: therapeutic implications.

Gansevoort RT, Navis GJ, Wapstra FH, de Jong PE, de Zeeuw D. Gansevoort RT, et al. Among authors: navis gj. Curr Opin Nephrol Hypertens. 1997 Mar;6(2):133-40. doi: 10.1097/00041552-199703000-00005. Curr Opin Nephrol Hypertens. 1997. PMID: 9146974 Review.

3

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.

van der Kleij FG, Schmidt A, Navis GJ, Haas M, Yilmaz N, de Jong PE, Mayer G, de Zeeuw D. van der Kleij FG, et al. Among authors: navis gj. Kidney Int Suppl. 1997 Dec;63:S23-6. Kidney Int Suppl. 1997. PMID: 9407415 Clinical Trial.

4

Risk factors for long-term renal survival after renal transplantation: a role for angiotensin-converting enzyme (insertion/deletion) polymorphism?

Broekroelofs J, Stegeman CA, Navis G, Tegzess AM, De Zeeuw D, De Jong PE. Broekroelofs J, et al. Among authors: navis g. J Am Soc Nephrol. 1998 Nov;9(11):2075-81. doi: 10.1681/ASN.V9112075. J Am Soc Nephrol. 1998. PMID: 9808093

5

Effect of proteinuria reduction on prevention of focal glomerulosclerosis by angiotensin-converting enzyme inhibition is modifiable.

de Boer E, Navis G, Wapstra FH, de Jong PE, de Zeeuw D. de Boer E, et al. Among authors: navis g. Kidney Int Suppl. 1999 Jul;71:S42-6. Kidney Int Suppl. 1999. PMID: 10412735 Free article.

6

Angiotensin-converting enzyme gene I/D polymorphism and renal disease.

Navis G, van der Kleij FG, de Zeeuw D, de Jong PE. Navis G, et al. J Mol Med (Berl). 1999 Nov;77(11):781-91. doi: 10.1007/s001099900063. J Mol Med (Berl). 1999. PMID: 10619438 Review.

7

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.

Bos H, Andersen S, Rossing P, De Zeeuw D, Parving HH, De Jong PE, Navis G. Bos H, et al. Among authors: navis g. Kidney Int Suppl. 2000 Apr;75:S32-7. Kidney Int Suppl. 2000. PMID: 10828759 Free article.

8

Role of genetic variability in the renin-angiotensin system in diabetic and nondiabetic renal disease.

Boonstra A, de Zeeuw D, de Jong PE, Navis G. Boonstra A, et al. Among authors: navis g. Semin Nephrol. 2001 Nov;21(6):580-92. doi: 10.1053/snep.2001.26804. Semin Nephrol. 2001. PMID: 11709806 Review.

9

Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.

van der Kleij FGH, de Jong PE, Henning RH, de Zeeuw D, Navis G. van der Kleij FGH, et al. Among authors: navis g. J Am Soc Nephrol. 2002 Apr;13(4):1025-1033. doi: 10.1681/ASN.V1341025. J Am Soc Nephrol. 2002. PMID: 11912262 Clinical Trial.

10

Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.

Luik PT, Hoogenberg K, Van Der Kleij FG, Beusekamp BJ, Kerstens MN, De Jong PE, Dullaart RP, Navis GJ. Luik PT, et al. Among authors: navis gj. Diabetologia. 2002 Apr;45(4):535-41. doi: 10.1007/s00125-001-0763-8. Diabetologia. 2002. PMID: 12032630 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

793 results

Search Page

Filters